RT Journal Article
SR Electronic
T1 Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001642
DO 10.1136/jitc-2020-001642
VO 9
IS 1
A1 Rose, April A N
A1 Armstrong, Susan M
A1 Hogg, David
A1 Butler, Marcus O
A1 Saibil, Samuel D
A1 Arteaga, Diana P
A1 Pimentel Muniz, Thiago
A1 Kelly, Deirdre
A1 Ghazarian, Danny
A1 King, Ian
A1 Kamil, Zaid Saeed
A1 Ross, Kendra
A1 Spreafico, Anna
YR 2021
UL http://jitc.bmj.com/content/9/1/e001642.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.